Potential role of fractalkine receptor expression in human renal fibrogenesis

M J Koziolek1, H Schmid, C D Cohen

  • 1Department of Nephrology and Rheumatology, Georg-August-University Goettingen, Robert-Koch-Street 40, D-37075 Goettingen, Germany. mkoziolek@med.uni-goettingen.de

Kidney International
|June 21, 2007
PubMed

Insights

This study found that CX3C receptor is upregulated in fibrotic kidneys, particularly on myofibroblasts. Oxidative stress, not inflammation, induces its expression, suggesting a role in kidney fibrosis progression.

Area of Science:

  • Nephrology
  • Cell Biology
  • Immunology

Background:

  • Renal interstitial fibrosis is a key factor in progressive kidney disease.
  • Chemokine/chemokine receptor signaling pathways are implicated in fibrosis development.
  • The role of CX3C receptor in renal fibrosis remains unclear.

Purpose of the Study:

  • To investigate the expression and role of the CX3C receptor in human renal interstitial fibrosis.
  • To determine factors that regulate CX3C receptor expression in renal fibroblasts.

Main Methods:

  • Real-time PCR and immunohistochemistry on human renal biopsies.
  • In vitro studies on renal fibroblasts.
  • Stimulation with CX3C ligand and reactive oxygen species.

Main Results:

  • CX3C receptor is expressed on myofibroblasts, mononuclear cells, and tubular epithelial cells in fibrotic kidneys.
  • CX3C receptor mRNA is significantly upregulated in fibrotic kidneys.
  • Hydrogen peroxide, a reactive oxygen species, upregulates CX3C receptor expression in fibroblasts.
  • CX3C ligand stimulation enhances fibroblast migration.

Conclusions:

  • Renal fibrosis is associated with increased CX3C receptor expression on renal fibroblasts.
  • Oxidative stress, rather than inflammatory or profibrotic cytokines, induces CX3C receptor expression.
  • CX3C receptor signaling may contribute to the pathogenesis of renal fibrosis.